Abstract

    Open Access Research Article Article ID: GJBBS-2-105

    Ruta graveolens Protects Against Isoniazid/Rifampicin-Induced Nephrotoxicity through Modulation of Oxidative Stress and Inflammation

    Ayman M Mahmoud*, Omnia E Hussein, Mousa O Germoush

    Background and Aim Drug-induced nephrotoxicity is a renal dyfunction that arises as a result of exposure to nephrotoxic drugs. Anti-tuberculosis therapy can cause nephrotoxicity and permanent kidney  damage. The  current  study  was  designed  to  evaluate  the  possible  protective  effects  of Ruta graveolens L. leaves extract against isoniazid/rifampicin-induced nephrotoxicity in rats.

    Methods:The experimental rats received isoniazid and rifampicin at dose level of 50 mg/kg, and 50 or 100 mg/kg/day Ruta graveolens leaves extract orally for 45 days.

    Results: Isoniazid/ rifampicin administration induced kidney injury evidenced by the histopathological alterations as well as significant (P<0.001) increase in serum creatinine, urea and uric acid. soniazid/rifampicin-intoxicated rats exhibited a significant increase in serum tumor necrosis factor alpha (P<0.001), and renal lipid peroxidation (P<0.01) and nitric oxide (P<0.001) levels. On the other hand, reduced glutathione level, and activity of superoxide dismutase and glutathione peroxidase were  markedly  (P<0.001)  declined  in  kidney  of  isoniazid/rifampicin-induced rats.Concomitant supplementation  with  either  50 or 100  mg/kg  dose  of Ruta  graveolens  leaves  extract  prevented  the isoniazid/rifampicin-induced biochemical and histopathological alterations.

    Conclusion:The present investigation confers new information on the protective mechanism of Ruta graveolens leaves extract on anti-tuberculosis therapy-induced nephrotoxicity.Ruta graveolens protects  against isoniazid/rifampicin-induced renal injury through attattenuation of inflammation and oxidative stress, and potentiation of the antioxidant defense system.

    Keywords: Renal injury; Rue; Oxidative stress; Inflammation; Anti-tuberculosis therapy

    Published on: Feb 22, 2016 Pages: 8-13

    Full Text PDF Full Text HTML DOI: 10.17352/gjbbs.000005
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat

    Indexing/Archiving

    Case Reports

    Pinterest on GJBBS